What is the current Price Target for the Marker Therapeutics, Inc. stock?

The average Marker Therapeutics, Inc. target price is $8.16. This is 585.71% higher than the current stock price. The highest price target is 782.35%, the lowest is 375.29%. 5 Analysts have issued a price target Marker Therapeutics, Inc. 2027 .

How high will the Marker Therapeutics, Inc. stock rise?

No reliable answer can be given as to how high the Marker Therapeutics, Inc. stock will rise. The performance of stocks, including the Marker Therapeutics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Marker Therapeutics, Inc. stock today?

The performance of Marker Therapeutics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Marker Therapeutics, Inc. stock fall?

The decline in Marker Therapeutics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Marker Therapeutics, Inc. Forecast, price target & analysts

$1.19

4.03%

Nasdaq, Sep 24, 04:00 pm EDT. Closed.

ISIN

US57055L1070

Symbol

MRKR

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Marker Therapeutics, Inc. Target price 2026 - Analyst rating & recommendation

Marker Therapeutics, Inc. Classifications & Recommendation

Buy

89%

Hold

11%

Marker Therapeutics, Inc. Price Target

Target Price	$8.16
Price	$1.19
Potential	585.71% register free of charge
Number of Estimates	5

	5 Analysts have issued a price target Marker Therapeutics, Inc. 2027 . The average Marker Therapeutics, Inc. target price is $8.16. This is 585.71% register free of charge higher than the current stock price. The highest price target is $10.50 782.35% register free of charge , the lowest is $5.66 375.29% register free of charge .
	A rating was issued by 9 analysts: 8 Analysts recommend Marker Therapeutics, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Marker Therapeutics, Inc. stock has an average upside potential 2027 of 585.71% register free of charge . Most analysts recommend the Marker Therapeutics, Inc. stock at Purchase.

Current Marker Therapeutics, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 08 2025
WBB Securities	Locked ➜ Locked	Locked	Apr 01 2025
Canaccord Genuity	Locked ➜ Locked	Locked	Mar 05 2025
Ladenburg Thalmann	Locked ➜ Locked	Locked	Oct 21 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 08 2025
Locked WBB Securities: Locked ➜ Locked	Apr 01 2025
Locked Canaccord Genuity: Locked ➜ Locked	Mar 05 2025
Locked Ladenburg Thalmann: Locked ➜ Locked	Oct 21 2024

Discover more stocks with a high price target

NIO ADR 101.75%

Alibaba Group Holding Ltd 67.67%

Tencent Holdings Ltd. 55.89%

Uber Technologies 48.83%

Siemens Energy 47.15%

Adidas 46.64%

BYD 44.49%

Deutsche Telekom 38.45%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now

The Apple stock at a glance with charts, current key metrics, news and stock analyses.

The Best Dividend Stocks in the Dividend Top Scorer list.

Stock Analyses of the Best Stocks Worldwide.

Start building wealth today